NanoString Technologies Inc (NASDAQ:NSTG)
| 1.64 BATS BZX Real-Time Price As of 12:34pm ET |  +0.04 / +2.50%Today’s Change | 1.40 Today|||52-Week Range 13.97 | -79.42% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $71.8M |
Company Description
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. It offers the GeoMx Digital Spatial Profiler, nCounter Analysis System product platforms, GeoMx Assays, nCounter Panels & Assays and CosMx Spatial Molecular. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June, 2003 and is headquartered in Seattle, WA.
Contact Information
NanoString Technologies, Inc. 530 Fairview Avenue North Seattle Washington 98109 |
Employees
Shareholders
| Other institutional | 78.07% |
| Mutual fund holders | 34.74% |
| Individual stakeholders | 15.60% |
Top Executives
| Robert Bradley Gray | President, Chief Executive Officer & Director |
| Mark A. Winham | Senior Vice President-Operations |
| Tom Bailey | Chief Financial Officer |
| Kenneth Thomas Bailey | Chief Financial Officer |
| Joseph M. Beechem | Chief Scientific Officer, SVP-R&D |
